Peptidomimetics—Tailored Enzyme Inhibitors
Tóm tắt
Peptides and proteins (there is no clear boundary between the two classes of compounds) are absolutely essential components of organisms in many ways. While proteins have biocatalytic functions and are important components of tissues, peptides play an important role in the organism as hormones, neurotransmitters, and neuromodulators. Peptides and their analogues have long been used in medicinal chemistry as therapeutic agents for pathological conditions generally characterized by a disruption of the interplay between messenger molecules or enzyme substrates and their targets, the receptors and enzymes. For various biochemical and biophysical reasons there is an increasing tendency towards the use of chemical “Trojan horses” known as peptidomimetics. The chances that such agents are active generally increase with the magnitude of the “deceptive effect”, in other words in proportion to the degree of conversion of a peptide into a non‐peptide. Rational design has become a catchphrase which is at present applied frequently to the development of peptidomimetics. New computer programs are invaluable tools in such design processes. However, in spite of the many advances already made, we are still far from the final goal, the de novo design of peptidomimetics. Rational design is nonetheless advancing rapidly, and it is already clear that developments in the area of peptidomimetics have given a great boost to peptide chemistry as a whole. This can be expected to continue, so that in future peptide chemistry may be characterized by a type of symbiotic alliance between peptides and non‐peptides.
Từ khóa
Tài liệu tham khảo
A peptidomimetic is defined as a substance having a secondary structure as well as other structural features analogous to that of the original peptide which allows it to displace the original peptide from receptors or enzymes. As a result the effects of the original peptide are inhibited (antagonist inhibitor) or duplicated (agonist).
Spatola A. F., 1993, Methods in Neurosciences, Vol. 13, 19
Morgan B. A., 1989, Annu. Rep. Med. Chem., 24, 244
Spatola A. F., 1983, Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins, Vol. VII, 267
1994, Nachr. Chem. Tech. Lab., 42, 164
Radunz H. E., 1992, GIT Fachz. Lab., 36, 869
(b)D.Merricks P. G.Sammes E. R.Walker K.Henrick M. M.McPartlin J. Chem. Soc. Perkin Trans. 11991 2169;
1992, Tetrahedron Lett., 33, 3689
Manesis N., 1986, Biopolymers, 25, 97
J.Di Maio B.Bellau J. Chem. Soc. Perkin Trans. 11989 1687.
(i)G.Valle M.Crisma C.Toniolo K.‐L.Yu R. L.Johnson J. Chem. Soc. Perkin Trans. 21989 83;
J.Zabrocki G. D.Smith J. B.Dunbar Jr. K. W.Marshall M.Toth G. R.Marshall Pept. Proc. Eur. Pept. Symp. 20th 19881989 295.
Jones R., 1988, Tetrahedron Lett., 29, 3858
G.Hölzemann Kontakte (Darmstadt)1991(1) 3;
Kontakte (Darmstadt)1991(2) 55;
Bailey P. D., 1990, Peptide Chemistry, 182
(a)K.Sato U.Nagai J. Chem. Soc. Perkin Trans. 119861231;
M.Kahn M.Lee H.Nakanishi J.Urban B.Gardner Proc. Am. Pept. Symp. 13th 1993 in press;
Müller K., 1993, Perspectives in Medicinal Chemistry, 513
Rich D. H., 1993, Med. Res. Rev., 13, 368
Tanford C., 1980, The Hydrophobic Effect: Formation of Micelles and Biological Membranes
J.Gante U.Anlauf R.Weitzel Pept. Proc. Eur. Pept. Symp. 21st 19921993 605.
Guichard G., 1993, Pept. Res., 6, 121
(a) Review:J.Gante Synthesis1989405;
(b)A. S.Dutta J. S.Morley J. Chem. Soc. Perkin Trans. 11975 1712.
Gante J., 1991, Chem. Ztg., 115, 215
C. J.Gray M.Quibell K. L.Jiang N.Bagett Innovation Perspect. Solid Phase Synth. Collect. Pap. Int. Symp. 2nd 19911992 295.
1993, Chemtracts: Macromol. Chem., 4, 80
Page M. I., 1990, Compr. Med. Chem., 2, 61
Rich D. H., 1990, Compr. Med. Chem., 2, 391
Collective term for enzymes that catalyze the hydrolytic cleavage of the peptide bond in proteins and peptides:Römpp Chemie‐Lexikon Thieme Stuttgart 1992 p. 3647.
Barrett A. J., 1986, Proteinase‐Inhibitors, Res. Monogr. Cell Tissue Physiol., 13, 301
Banner D., 1993, Perspectives of Medicinal Chemistry, 27
Rich D. H., 1986, Res. Monogr. Cell Tissue Physiol., 12, 153
Rich D. H., 1986, Res. Monogr. Cell Tissue Physiol., 12, 179
Hofmann T., 1984, Biochemistry, 23, 5253
Rich D. H., 1990, Compr. Med. Chem., 2, 414
Rich D. H., 1990, Compr. Med. Chem., 2, 400
(a)M.Szelke D. M.Jones B.Atrash A.Hallett B. J.Leckie Pept. Struct. Funct. Proc. Am. Pept. Symp. 8th 1983 1983 579;
Clozel J.‐P., 1993, Arzneim. Forsch., 43, 260
Ogihara T., 1992, Hypertension, 20
(b)C. H.Hassall A.Krohn C. J.Moody W. A.Thomas J. Chem. Soc. Perkin Trans. 11984 155.
Rich D. H., 1990, Compr. Med. Chem., 2, 400
Shirota M., 1992, Arzneim. Forsch., 42, 1430
Wiley R. A., 1993, Med. Chem. Rev., 13, 350
Mustard J. F., 1970, Phamacol. Rev., 22, 97
Jaques L. B., 1980, Pharmacol. Rev., 31, 99
Markwardt F., 1985, Biomed. Biochim. Acta, 44, 1007
Talbot M. D., 1990, Drugs News Perspect., 3, 357
Kaiser B., 1991, Pharmazie, 46, 128
W.Stüber(Behringwerke AG) EP‐B 508220 1992.
W.Stüber unpublished see also ref. [128].
Owen T. J., 1988, J. Chem. Chem., 31, 1009
Williams R. M., 1993, Biomed. Appl. Biotechnol., 1, 204
Grant S. K., 1993, Biomed. Appl. Biotechnol., 1, 349
H. L.Sham D. A.Betebenner C.Zhao N. E.Wideburg A.Saldivar D. J.Kempf J. J.Plattner D. W.Norbeck J. Chem. Soc. Chem. Cutmmun.1993 1052.
Roques B. P., 1986, NIDA Res. Monogr., 70, 128
Ruskoako H., 1992, Pharmcol. Rev., 44, 479
Sybertz E. J., 1989, J. Pharmacol. Exp. Ther., 250, 624
Woessner J. F., 1980, Collagenases in Normal and Pathological Tissue, 223
Barrett A. J., 1980, Mammalian Proteinases: A Glossary and Bibliography, Vol. 1.
Rich D. H., 1993, Perspectives in Medicinal Chemistry, 15
Tanford C., 1980, The Hydrophobic Effect: Formation of Micelles and Biological Membranes
Bartlett P. A., 1989, Molecular Recognition: Chemical and Biochemical Problems, 182
(a)Addendum: Many publications on the topics in this review have appeared since the submission of this manuscript. A selection (up to April 1994) are listed here. Structure:M.Quibell W. G.Turnell T.Johnson J. Chem. Soc. Perkin Trans. 119932843;
Patel A., 1993, Prog. Med. Chem., 30, 328
French J., 1994, J. Pharmacol. Exp. Ther., 268, 180
Sham H. L., 1993, FEBS Lett., 329
Okamoto S., 1993, Methods Enzymol., 222, 238